socalTECH

JUNE 11, 2021

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX. Janux Therapeutics is developing T cell engager immunotherapies.

Pricing 113

Pricing Avalon Capital Marketing 113

socalTECH

AUGUST 4, 2014

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. Otonomy has applied to list on the NASDAQ Global Market as OTIC. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit otic pricing' and $16.00 READ MORE>>.

Pricing 147

Pricing Avalon San Diego Acquisition 147

socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. and $16.00

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

FEBRUARY 5, 2014

Goleta-based medical equipment maker Inogen has set the pricing range for its IPO, saying in a filing with the SEC that it expects its stock to price at between $16.00 The company is offering up 3,529,411 shares of its stock, and plans to trade on the NASDAQ Global Market as INGN. and $18.00 READ MORE>>.

Avalon 214

Avalon Pricing Acquisition Marketing 214

socalTECH

JANUARY 26, 2017

Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. The company now trades as ANAB on the NASDAQ Global Select Market. per share, at the midpoint of its $14.00 READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

AUGUST 13, 2014

San Diego-based biopharmaceuticals firm Otonomy was up today in early trading, after pricing 6.25 today after its debut on the NASDAQ Global Market as OTIC. The company priced at the high end of its initial estimated IPO range, which was $14.00 million shares of its common stock at $16.00 per share last night. READ MORE>>.

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

DECEMBER 16, 2011

Among the biggest winners of the IPO of Zynga is San Diego-based Avalon Ventures , which owned 32,169,401 shares of Zynga before the IPO, a stake which was worth $321M based on Zynga's opening price this morning. Zynga priced at $10.00 to $10.00; the firm was trading slightly down near close of market, and had ranged from $9.00

Southern California 145

Southern California SoCal Avalon San Diego 145